Showing results (71-80 of 182) with videos related to

Sort By:
Pageof 19
Medicine|February 1, 2019
Sedation for terminally ill cancer patients: A multicenter retrospective cohort study in South KoreaYoung Saing Kim, Haa-Na Song, Jin Seok Ahn, et al.
Veterinary Dermatology|February 12, 2025
Prevalence and lesion distribution of atopic dermatitis in small-to-medium breed dogs in KoreaJi-Hye Ryu, Jung-Hun Kang, Yeong-Hun Kang, et al.
Cancer Chemotherapy and Pharmacology|January 20, 2009
Phase II trial of S-1 in combination with gemcitabine for chemo-naïve patients with locally advanced or metastatic pancreatic cancerGyeong-Won Lee, Hye Jung Kim, Ji-Hyun Ju, et al.
Investigational New Drugs|March 19, 2010
Phase II study of irinotecan/S-1 combination chemotherapy for patients with oxaliplatin-refractory colorectal cancerSung Yong Oh, Young-Tae Ju, Sang-Kyung Choi, et al.
Cancer Research and Treatment|February 13, 2014
Chemotherapy in advanced gastric cancer patients associated with disseminated intravascular coagulationIn Gyu Hwang, Jin Hwa Choi, Se Hoon Park, et al.
Investigational New Drugs|February 4, 2012
A phase II trial of Erlotinib in combination with gemcitabine and cisplatin in advanced pancreatic cancerIn Gyu Hwang, Joung-Soon Jang, Sung Yong Oh, et al.
Asia-Pacific Journal of Clinical Oncology|June 8, 2017
Using primary tumor volumetry to predict treatment outcome for patients with oropharyngeal cancer who were treated with definitive chemoradiotherapyYun Hee Lee, Jin Ho Song, Hoon-Sik Choi, et al.
Chemotherapy|May 1, 2015
Gemcitabine plus vinorelbine as the second-line treatment and beyond in elderly patients with platinum-pretreated advanced non-small cell lung cancerSe-Il Go, Won Sup Lee, Gyeong-Won Lee, et al.
Lung Cancer (Amsterdam, Netherlands)|February 15, 2014
Clinical significance of the neutrophil-lymphocyte ratio in venous thromboembolism patients with lung cancerSe-Il Go, Anna Lee, Un Seok Lee, et al.
Leukemia & Lymphoma|October 29, 2009
Is inactivation of O6-methylguanine DNA methyltransferase still a favorable prognostic factor of patients with diffuse large B-cell lymphoma in the era of R-CHOP chemotherapy?Gyeong-Won Lee, Jung-Hun Kang, In-Suk Kim, et al.
Pageof 19